Yousry El Bulkiny.

Pharma without Boarder Creating global companies having sustainment portfolio Strategic alliance with global manufacturing players.

President of Canadian Pharma Services. Since it’s initiation in Canada in 2011, I have successfully created strategic partnerships with well known businesses in Canada, Europe, GCC, North Africa, and the Middle East. These partnerships include : 1) Kerremezzat GmBH (Austria) 2) Ironwood Clay (Canada) 3) Saviour Health (Athens)

- Driving the growth of revenue and profit margins. - Creating a solid succession plan for major dept. to support future growth strategy - Responsible for all contracts and lease agreements with key stakeholders & clients - Interpreting financial data and drawing conclusions. Analysing operating costs and efficiency. - Identify skills gaps and devise hiring strategies. - Winning business from key target clients. - Implementing systems that reward good staff performance & competence. - Liaising with key strategic suppliers, internal functions and customers to define KPI's. - Reviewing and monitoring all budget expenditure. Motivating & providing strong leadership to all departments. - Developing the company’s commercial processes including account management and marketing.

Guided 15 people (2 Supervisors & 13 Representatives) for Sales activities, control of free goods & discounts to customers, utilization of new product launch and line extension, area development programs, etc. - Enhanced sale of GW Eastern Province end of 1996 (18 months after integration) grew from Sterling 3.66 Millions in 95 to Sterling 5.95 Millions 96. Instrumental in the following: - Budget extension by 16%. - Company growth by 8%. - Cash discount and Bonus less by 20%. - Sales Force size was 30% less than size of 2 Companies before integration (21 before and now 15 people).

Was shifted from Riyadh to Jeddah after Western Area Sales Manager’s resignation; managed 4 Supervisors + 40 Medical Representatives. - Upgrading of institution sector in Western province in terms of new product launch in formulary and developing established products portfolio. - Upgrading private sector to decrease reliance on a very fragile business in Jeddah “Dermovate” by more development and other solid business in therapeutic area like Gastro, Antibiotic, Asthma, Allergic rhinitis.

1-Managing 10 members (2 Supervisors, 8 Reps) 2- Identifying, creating, and prioritizing the agreed business plan tasks.MOH activity, distribution of goods, liquidation of MOH’s stock, attend International symposiums, launch of new products, and monitoring ROI, etc. 3-Effectively handling product introduction as well as consumption of products like Imigran 100, Flixonase, Zofran, & Servent, BDP). 4-Oversaw the Upgrading of Glaxo institutional sector formerly status (line extension or NCE’).

Led 2 Medical Reps located in Jeddah, 2 Medical Reps in Dammam, 6 Medical Reps in Riyadh for Creating 1st Institutional Team in terms of: Status evaluation of Glaxo in Institutional sector. Staffing Executing agreed institutional plans through the following objectives: Establishing Glaxo Welcome Institutional portfolio New Product Introduction and line extension. Setting priorities / Area Sales plan. Staff development. Staff Coaching (Jeddah, Riyadh, Dammam). Staff appraisal

Joined as Medical Rep. { Jeddah & South Area) Promoting company products in Jeddah Domestic Market (Hospitals/ Polyclinics/ Street Clinics) as well as in Western South area (Institutional Hospital/Trade Market).

Promoting Bristol Myers Nutritional and therapeutic special formula in the western area

Promoting Ophthalmology products,Contact lens Care Products and Intra-ocular lenses.

-Managing both out-patients Pharmacy and small manufacturing unit of hemodialysis solutions designated for Gambro Machines. -Central Purchasing for Maadi Hospital annual tenders.